Key result
Periostin promotes epithelial-mesenchymal transition and metastasis in lung cancer by repressing miR-381 via the ERK/p38 signaling pathway, and higher expression correlates with poor overall survival.
p-value: p=0.021
Periostin promotes epithelial-mesenchymal transition in lung cancer via the MAPK/miR-381 axis, suggesting it may serve as a therapeutic target for lung cancer metastasis.
// Wei-Wei Hu 1, * , Po-Chun Chen 2, 3, 4, * , Jun-Ming Chen 2 , Yue-Ming Wu 1 , Po-Yi Liu 5, 6 , Chih-Hao Lu 2 , Yu-Feng Lin 7 , Chih-Hsin Tang 4, 5, 8 and Chia-Chia Chao 9 1 Department of Thoracic Surgery, Dongyang People's Hospital, Dongyang, China 2 Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan 3 Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan 4 Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan 5 Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan 6 Department of Thoracic Surgery, Changhua Christian Hospital, Changhua, Taiwan 7 Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu, Taiwan 8 Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan 9 Department of Respiratory Therapy, Fu-Jen Catholic University, New Taipei, Taiwan * These authors have contributed equally to this work Correspondence to: Chia-Chia Chao, email: 095457@mail.fju.edu.tw Chih-Hsin Tang, email: chtang@mail.cmu.edu.tw Keywords: periostin, lung cancer, epithelial-mesenchymal transition, miR-381, MAPK Received: April 14, 2017 Accepted: May 29, 2017 Published: July 15, 2017 ABSTRACT Periostin (POSTN, PN, or osteoblast-specific factor OSF-2) is a multifunctional cytokine that signals between the cell and the extracellular matrix. Periostin plays an important role in tumor development and is involved in carcinoma cell epithelial-mesenchymal transition (EMT), whereby mature epithelial cells undergo phenotypic morphological changes and become invasive, motile cells. Here, we discuss the molecular mechanisms involved in periostin-induced promotion of EMT in lung cancer cells. Online TCGA datasets demonstrate the prognostic relevance of periostin in lung cancer; a higher periostin level correlates with poor overall survival. Similarly, our IHC results show that high periostin expression is positively correlated with the EMT markers Snail and Twist, as well as stage of lung cancer. We found that recombinant periostin induces the EMT phenotype in lung cancer cells through the p38/ERK pathway, while pretreatment with chemical inhibitors prevented periostin-induced EMT induction. Moreover, we found that periostin regulates EMT by repressing microRNA-381 (miR-381) expression, which targets both Snail and Twist. Using the miR-381 mimic, we dramatically reversed periostin-induced Snail and Twist expression. Furthermore, periostin knockdown dramatically affected EMT markers and cell migration potential. The role of periostin in lung cancer progression is elucidated by the in vivo mouse model. Our findings indicate that changes in periostin expression in lung cancer may serve as a therapeutic target for the treatment of lung cancer metastasis.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2017) studied Non-small cell lung cancer (NSCLC) (n=504). Periostin vs. Low periostin expression / Control was evaluated on Epithelial-mesenchymal transition (EMT) and overall survival (p=0.021). Periostin promotes epithelial-mesenchymal transition and metastasis in lung cancer by repressing miR-381 via the ERK/p38 signaling pathway, and higher expression correlates with poor overall survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: